Healthcare -
Biotechnology - NASDAQ - US
$ 14.13
-4.33 %
$ 1.44 B
Market Cap
-3.95
P/E
DYN - LONG-TERM DEBT
Long-term Debt DYN - Dyne Therapeutics, Inc.
22.7 M
LAST VALUE
-37.17%
2 YEAR CAGR
46.40%
5 YEAR CAGR
-36.03%
10 YEAR CAGR